» Articles » PMID: 19834013

Biology of Vascular Malformations of the Brain

Overview
Journal Stroke
Date 2009 Oct 17
PMID 19834013
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: This review discusses recent research on the genetic, molecular, cellular, and developmental mechanisms underlying the etiology of vascular malformations of the brain (VMBs), including cerebral cavernous malformation, sporadic brain arteriovenous malformation, and the arteriovenous malformations of hereditary hemorrhagic telangiectasia. Summary of Review- The identification of gene mutations and genetic risk factors associated with cerebral cavernous malformation, hereditary hemorrhagic telangiectasia, and sporadic arteriovenous malformation has enabled the development of animal models for these diseases and provided new insights into their etiology. All of the genes associated with VMBs to date have known or plausible roles in angiogenesis and vascular remodeling. Recent work suggests that the angiogenic process most severely disrupted by VMB gene mutation is that of vascular stabilization, the process whereby vascular endothelial cells form capillary tubes, strengthen their intercellular junctions, and recruit smooth muscle cells to the vessel wall. In addition, there is now good evidence that in some cases, cerebral cavernous malformation lesion formation involves a genetic 2-hit mechanism in which a germline mutation in one copy of a cerebral cavernous malformation gene is followed by a somatic mutation in the other copy. There is also increasing evidence that environmental second hits can produce lesions when there is a mutation to a single allele of a VMB gene.

Conclusions: Recent findings begin to explain how mutations in VMB genes render vessels vulnerable to rupture when challenged with other inauspicious genetic or environmental factors and have suggested candidate therapeutics. Understanding of the cellular mechanisms of VMB formation and progression in humans has lagged behind that in animal models. New knowledge of lesion biology will spur new translational work. Several well-established clinical and genetic database efforts are already in place, and further progress will be facilitated by collaborative expansion and standardization of these.

Citing Articles

Genetic inactivation of the β1 adrenergic receptor prevents cerebral cavernous malformations in zebrafish.

Li W, McCurdy S, Lopez-Ramirez M, Lee H, Ginsberg M Elife. 2025; 13.

PMID: 39991834 PMC: 11849999. DOI: 10.7554/eLife.99455.


An Updated Review on the Pathogenesis of Brain Arteriovenous Malformations and Its Therapeutic Targets.

Ota T J Neuroendovasc Ther. 2025; 19(1).

PMID: 39958460 PMC: 11826344. DOI: 10.5797/jnet.ra.2024-0008.


Ectopic recurrence following treatment of arteriovenous malformations in an adult: A case report and review of literature.

Cao W, Li J, Guo P, Song L World J Radiol. 2024; 16(10):537-544.

PMID: 39494139 PMC: 11525823. DOI: 10.4329/wjr.v16.i10.537.


Cerebellar Venous Hemangioma: Two Case Reports and Literature Review.

Harapan B, Ruf V, Herms J, Forbrig R, Schichor C, Thorsteinsdottir J J Clin Med. 2024; 13(19).

PMID: 39407873 PMC: 11477381. DOI: 10.3390/jcm13195813.


Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations.

Chen C, Bao Y, Ju S, Jiang C, Zou X, Zhang X Biomark Res. 2024; 12(1):57.

PMID: 38835051 PMC: 11151651. DOI: 10.1186/s40364-024-00603-y.


References
1.
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C . Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999; 126(14):3047-55. DOI: 10.1242/dev.126.14.3047. View

2.
Shi C, Shenkar R, Batjer H, Check I, Awad I . Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg. 2007; 107(5):1023-6. DOI: 10.3171/JNS-07/11/1023. View

3.
Xu K, LaManna J . Chronic hypoxia and the cerebral circulation. J Appl Physiol (1985). 2006; 100(2):725-30. DOI: 10.1152/japplphysiol.00940.2005. View

4.
Bauer H, Bauer H, Lametschwandtner A, Amberger A, Ruiz P, Steiner M . Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res. 1993; 75(2):269-78. DOI: 10.1016/0165-3806(93)90031-5. View

5.
Ma X, Labinaz M, Goldstein J, Miller H, Keon W, Letarte M . Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 2000; 20(12):2546-52. DOI: 10.1161/01.atv.20.12.2546. View